Author:
Saad F.,Brown J.E.,Van Poznak C.,Ibrahim T.,Stemmer S.M.,Stopeck A.T.,Diel I.J.,Takahashi S.,Shore N.,Henry D.H.,Barrios C.H.,Facon T.,Senecal F.,Fizazi K.,Zhou L.,Daniels A.,Carrière P.,Dansey R.
Reference41 articles.
1. Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors;Bamias;J Clin Oncol,2005
2. Osteonecrosis of the jaw associated with chronic bisphosphonates therapy: an Italian experience;Cafro;Blood (ASH Annual Meeting Abstracts),2005
3. Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates: evidence of increased risk after treatment with zoledronic acid;Dimopoulos;Haematologica,2006
4. The incidence of osteonecrosis of the jaw (ONJ) in patients with multiple myeloma who receive biphosphonates depends on the type of biphosphonate;Dimopoulos;Blood (ASH Annual Meeting Abstracts),2005
5. Osteonecrosis of the jaw and bisphosphonates;Durie;N Engl J Med,2005
Cited by
614 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献